Events in April 2020
MonMonday | TueTuesday | WedWednesday | ThuThursday | FriFriday |
---|---|---|---|---|
March 30, 2020
|
March 31, 2020(2 events)
10:30 am: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 10:30 am - 11:30 am
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. The results are dramatic in terms of informing site choices, picking the best sites and constructing realistic site plans that stay on track. Learn how companies are accelerating enrollment and reducing the risk of poor enrollment using key data principles and a solid analysis framework. 5:30 pm: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 5:30 pm - 6:30 pm
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. The results are dramatic in terms of informing site choices, picking the best sites and constructing realistic site plans that stay on track. Learn how companies are accelerating enrollment and reducing the risk of poor enrollment using key data principles and a solid analysis framework. |
April 1, 2020(2 events)
10:30 am: R&D Advantage ReportR&D Advantage Report 10:30 am - 11:30 am
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators from productivity to value in BioPharma R&D. Sponsors Only 5:30 pm: R&D Advantage Report: Key Productivity Metrics for R&DR&D Advantage Report: Key Productivity Metrics for R&D 5:30 pm - 6:30 pm
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. Sponsors Only |
April 2, 2020(2 events)
10:30 am: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 10:30 am - 11:30 am
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. The results are dramatic in terms of informing site choices, picking the best sites and constructing realistic site plans that stay on track. Learn how companies are accelerating enrollment and reducing the risk of poor enrollment using key data principles and a solid analysis framework. 5:30 pm: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 5:30 pm - 6:30 pm
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. The results are dramatic in terms of informing site choices, picking the best sites and constructing realistic site plans that stay on track. Learn how companies are accelerating enrollment and reducing the risk of poor enrollment using key data principles and a solid analysis framework. |
April 3, 2020(2 events)
10:30 am: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 10:30 am - 11:30 am
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only 5:30 pm: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 5:30 pm - 6:30 pm
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only |
April 6, 2020
|
April 7, 2020(2 events)
10:30 am: Country Analytics & OptimizationCountry Analytics & Optimization 10:30 am - 11:30 am
Country level analytics are essential for understanding how the timeline for your trial will unfold. This webinar highlights key performance analytics and KMR proprietary advanced statistics used to evaluate country performance while highlighting the importance of using a trusted data source and the details around the data used to compile country level analytics, i.e., it needs to be derived from the country. 5:30 pm: Country Analytics & OptimizationCountry Analytics & Optimization 5:30 pm - 6:30 pm
Country level analytics are essential for understanding how the timeline for your trial will unfold. Essential metrics for country selection and planning will be presented along with a framework for how true country level analytics are constructed from country specific source data. |
April 8, 2020(1 event)
10:30 am: LIVE Measuring and Improving R&D Success RatesLIVE Measuring and Improving R&D Success Rates 10:30 am - 11:30 am
Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing more nuanced risk based performance models. The session identifies a variety of ways to measure success rates and how various aspects of performance including licensing and acquisition along with divestiture can bias results. Companies that want an unbiased and unvarnished assessment of their performance come to KMR as their trusted data source and analytics partner. Sponsors Only |
April 9, 2020(2 events)
10:30 am: Site ContractsSite Contracts 10:30 am - 11:30 am
This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. 5:30 pm: Site ContractsSite Contracts 5:30 pm - 6:30 pm
This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. |
April 10, 2020(2 events)
10:30 am: Enrollment Planning AnalyticsEnrollment Planning Analytics 10:30 am - 11:30 am
Learn how quality data, the right analytics and the application of those analytics can be instrumental in getting trials completed more quickly and more effectively. Making informed choices based on trusted source data is the key. 5:30 pm: Enrollment Planning AnalyticsEnrollment Planning Analytics 5:30 pm - 6:30 pm
Learn how quality data, the right analytics and the application of those analytics can be instrumental in getting trials completed more quickly and more effectively. Making informed choices based on trusted source data is the key. |
April 13, 2020
|
April 14, 2020(2 events)
10:30 am: Measuring and Improving R&D Success RatesMeasuring and Improving R&D Success Rates 10:30 am - 11:30 am
Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing more nuanced risk based performance models. The session identifies a variety of ways to measure success rates and how various aspects of performance including licensing and acquisition along with divestiture can bias results. Companies that want an unbiased and unvarnished assessment of their performance come to KMR as their trusted data source and analytics partner. Sponsors Only 5:30 pm: Measuring and Improving R&D Success RatesMeasuring and Improving R&D Success Rates 5:30 pm - 6:30 pm
Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing more nuanced risk based performance models. The session identifies a variety of ways to measure success rates and how various aspects of performance including licensing and acquisition along with divestiture can bias results. Companies that want an unbiased and unvarnished assessment of their performance come to KMR as their trusted data source and analytics partner. Sponsors Only |
April 15, 2020(2 events)
10:30 am: Clinical Cycle Time Program: Establishing A Framework For Company PerformanceClinical Cycle Time Program: Establishing A Framework For Company Performance 10:30 am - 11:30 am
Measuring the performance of clinical trials requires a solid framework of how and what to measure grounded by standard definitions and an unbiased third party to ensure data integrity. The data is just the beginning, KMR Group creates benchmarks and advanced analytics that drive insight from specific pain points to statistically validated drivers of duration. Companies participating in the program benefit from access to reports, tools, members only webinars, user meetings and options for a la carte or project specific consulting opportunities that are all grounded by our peerless data sources. Find out more about why the most innovative companies in the industry rely on KMR to help them drive performance improvements by over 30% using the most reliable and trusted dataset in the industry. 5:30 pm: Clinical Cycle Time Program: Establishing A Framework For Company PerformanceClinical Cycle Time Program: Establishing A Framework For Company Performance 5:30 pm - 6:30 pm
Measuring the performance of clinical trials requires a solid framework of how and what to measure. Join this webinar to learn about the key metrics used to evaluate clinical trial cycle times and how to benchmark your performance. Learn too about KMR proprietary advanced scoring and ranking methods to help normalize for protocol complexity and more. |
April 16, 2020(2 events)
10:30 am: Site ContractsSite Contracts 10:30 am - 11:30 am
This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. 5:30 pm: Site ContractsSite Contracts 5:30 pm - 6:30 pm
This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. |
April 17, 2020
|
April 20, 2020
|
April 21, 2020(2 events)
10:30 am: Measuring and Improving R&D Success RatesMeasuring and Improving R&D Success Rates 10:30 am - 11:30 am
Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing more nuanced risk based performance models. The session identifies a variety of ways to measure success rates and how various aspects of performance including licensing and acquisition along with divestiture can bias results. Companies that want an unbiased and unvarnished assessment of their performance come to KMR as their trusted data source and analytics partner. Sponsors Only 5:30 pm: Measuring and Improving R&D Success RatesMeasuring and Improving R&D Success Rates 5:30 pm - 6:30 pm
Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing more nuanced risk based performance models. The session identifies a variety of ways to measure success rates and how various aspects of performance including licensing and acquisition along with divestiture can bias results. Companies that want an unbiased and unvarnished assessment of their performance come to KMR as their trusted data source and analytics partner. Sponsors Only |
April 22, 2020
|
April 23, 2020(2 events)
10:30 am: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 10:30 am - 11:30 am
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. The results are dramatic in terms of informing site choices, picking the best sites and constructing realistic site plans that stay on track. Learn how companies are accelerating enrollment and reducing the risk of poor enrollment using key data principles and a solid analysis framework. 5:30 pm: Site Selection Using Advanced AnalyticsSite Selection Using Advanced Analytics 5:30 pm - 6:30 pm
Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. Easier said than done. Learn the details around what it takes to evaluate named site performance from standardizing site information to creating performance scores including KMR’s proprietary 5 Star Rankings. |
April 24, 2020
|
April 27, 2020
|
April 28, 2020
|
April 29, 2020
|
April 30, 2020
|
May 1, 2020
|